Breakthroughs are made possible by you! Find a Pfizer clinical trial and learn more about our commitment to clinical trial participants.
Go to Pfizer Clinical Trials SiteDetails Clinical Trials Learn more about the process of joining a clinical trial and find a trial near you. Guide to Clinical Trials Clinical Trials in Children Data & Results Integrity & Transparency Diversity in Trials ...
Find a Pfizer clinical trial with our search tool. Input a specific condition or keyword to see relevant results. Learn more at PfizerClinicalTrials.com.
Clinical Trial Data: Accessible and Transparent We believe that it is important for researchers, trial participants, regulators, and others acting in the best interest of patients to have access to clinical trial information to advance medical understanding and progress. It’s also important that th...
“While we expect more mature immune response data from the clinical trial of our Omicron BA.4/BA.5-adapted bivalent vaccine in the coming weeks, we are pleased to see encouraging responses just one week after vaccination in younger and older adults. These early dat...
About Pfizer's initiative to make clinical trials more participant-friendly through the decentralized "Clinical Trial Anywhere" model; a suite of solutions like remote sample collection, alternative study conduct locations, home health, and mobile units to reduce the need for in-person visits. ...
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) February 2024 02.12.2024 Corporate Partnerships UT Southwestern collaborates with Pfizer to develop improved RNA Delivery Technologies ...
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating the safety, tolerability, and immunogenicity of the companies' Omicron BA.4/BA.5-adapted ...
(NYSE: PFE) today announced that updated clinical trial data for vepdegestrant (ARV-471) will be presented at the 2023 San Antonio Breast Cancer Symposium (SABCS). Vepdegestrant is a novel oral PROteolysis TArgeting Chimera (PROTAC®) estrogen receptor (ER) degrader current...
Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid ArthritisThe article reports on the announcement of Pfizer Inc. regarding the top line results from the Oral Scan Phase 3 study of tofacitinib in patients with active...